MEDUSA Study - Migraine: Evaluation of Diagnosis, Utilisation of Services and Application
MEDUSA
Evaluation of Patient Experiences of Migraine Management and Feasibility of a Digital Headache Diary in Primary Care Setting: a Prospective Cohort Survey and Evaluative Study
1 other identifier
interventional
887
1 country
1
Brief Summary
Migraine is a very common condition characterised by frequent severe headaches that are very debilitating. Although the frequency and severity does reduce as patient's age, particularly above the age of 70, in younger and working age people this condition has a significant impact on people's lives. Patients with migraine are typically diagnosed and managed in primary care, but can also be treated by neurologists. Recently, NHS England has published guidance for clinical staff to optimise patient management: reduce admissions to hospital for migraine and improve the setting in which patients are seen. One recommendation is the increased use of headache diaries by patients. These may help patients and doctors to improve migraine diagnosis and its treatment, for example by identifying if there are triggers for getting a migraine attack. With technological advancements, there are now computer/phone applications (Apps) that can be used instead of a paper diary. The Curelator N1 Headache App is one of such migraine specific Apps. In this study, the investigators aim to evaluate if primary care migraine patients are open to using a digital headache diary App, and how compliant users of the App will be. The investigators also aim to assess patient feedback on the use of the N1 Headache App, and if its use aids them in the management of their migraine.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 15, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 20, 2021
CompletedFirst Submitted
Initial submission to the registry
July 14, 2023
CompletedFirst Posted
Study publicly available on registry
August 7, 2023
CompletedAugust 7, 2023
July 1, 2023
10 months
July 14, 2023
July 27, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
patient interest in N1 Headache App
percentage of survey responders who indicate they are willing to trial the N1 Headache App
30 days
user compliance for N1 Headache App
percentage of participants who consent to using the App who comply with daily use in 90 day trial period
90 days
Secondary Outcomes (3)
previous use of digital diary Apps for migraine
30 days
usefulness of N1 Headache App: percentage patients who identify a migraine trigger
90 days
Health Confidence and digital diary App
90 days
Study Arms (1)
N1-Headache App
EXPERIMENTALAll participants used the N1-HEadache App, a digital migraine diary that allows identification of triggers/protectors for migraine (as well as monitoring of medication use)
Interventions
Digital application allowing patients to monitor their migraines, and to identify triggers and/or protectors for their migraines.
Eligibility Criteria
You may qualify if:
- Primary care patients diagnosed with or attending their GP practice ('coded for') migraine in the last 5 years. This may therefore be newly diagnosed patients or patients with long-standing migraine who attended their GP practice about their condition.
- Patients aged ≥ 16 years
- Mental capacity to give consent and not using an interpreter for GP consultations (ie competent in English and capacity to complete postal survey)
- Part 2 only:
- Completion of complete part 1 survey, including indication that patient still has ongoing migraine issues.
- Access to email, internet and Apple or Android technology (ie smartphone, tablet or computer)
You may not qualify if:
- Under the age of 16 years
- Unable to fully understand the consent process and provide informed consent due to either language barriers or mental capacity
- The patient has concurrent (medical) conditions that in the opinion of the investigator may compromise their capacity to complete the survey. Examples would be current severe ill health episode.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Research & Development Department
Carlisle, Cumbria, CA1 3SX, United Kingdom
Related Publications (1)
Jonker L, Fitzgerald L, Vanderpol J, Fisher S. Digital diary App use for migraine in primary care: Prospective cohort study. Clin Neurol Neurosurg. 2022 May;216:107225. doi: 10.1016/j.clineuro.2022.107225. Epub 2022 Mar 25.
PMID: 35364371RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Stacey J Fisher, MD
substantive employee
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 14, 2023
First Posted
August 7, 2023
Study Start
October 15, 2020
Primary Completion
July 31, 2021
Study Completion
December 20, 2021
Last Updated
August 7, 2023
Record last verified: 2023-07
Data Sharing
- IPD Sharing
- Will not share